About the job
Join Axsome Therapeutics, a pioneering biopharmaceutical company committed to transforming the landscape of central nervous system (CNS) treatments. Our mission revolves around addressing critical care gaps through innovative scientific breakthroughs. We specialize in creating unique products that leverage novel mechanisms of action, making significant strides in improving patient outcomes. Our award-winning neuroscience portfolio features FDA-approved therapies for major depressive disorder, excessive daytime sleepiness linked to narcolepsy and obstructive sleep apnea, and migraine, alongside numerous late-stage development programs targeting a diverse array of serious neurological and psychiatric disorders that affect over 150 million individuals in the United States. Together, we endeavor to tackle some of the most daunting challenges faced by patients and their families, enabling them to thrive. For further details, please visit www.axsome.com and connect with us on LinkedIn.

